Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
The parents of a young man who was shot by a gang have launched a fresh appeal to catch his killers, ten years on from his death.
Ross has this week's early morning forecast.
The young Huddersfield Town fan carried the match ball ahead of England’s match with Panama.